BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19054816)

  • 1. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.
    Rueda B; Simeon C; Hesselstrand R; Herrick A; Worthington J; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Gonzalez-Escribano MF; Coenen MJ; Lambert N; Nelson JL; Radstake TR; Martin J
    Ann Rheum Dis; 2009 Oct; 68(10):1618-20. PubMed ID: 19054816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population.
    Kawaguchi Y; Ota Y; Kawamoto M; Ito I; Tsuchiya N; Sugiura T; Katsumata Y; Soejima M; Sato S; Hasegawa M; Fujimoto M; Takehara K; Kuwana M; Yamanaka H; Hara M
    Ann Rheum Dis; 2009 Dec; 68(12):1921-4. PubMed ID: 19054818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a CTGF gene polymorphism and systemic sclerosis in a French population.
    Granel B; Argiro L; Hachulla E; Fajardy I; Weiller PJ; Durand JM; Frances Y; Dombey AM; Marquet S; Lesavre N; Disdier P; Bernard F; Hatron PY; Chevillard C
    J Rheumatol; 2010 Feb; 37(2):351-8. PubMed ID: 20032097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
    Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
    Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.
    Rueda B; Gourh P; Broen J; Agarwal SK; Simeon C; Ortego-Centeno N; Vonk MC; Coenen M; Riemekasten G; Hunzelmann N; Hesselstrand R; Tan FK; Reveille JD; Assassi S; Garcia-Hernandez FJ; Carreira P; Camps M; Fernandez-Nebro A; Garcia de la Peña P; Nearney T; Hilda D; Gónzalez-Gay MA; Airo P; Beretta L; Scorza R; Radstake TR; Mayes MD; Arnett FC; Martin J
    Ann Rheum Dis; 2010 Apr; 69(4):700-5. PubMed ID: 19815934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.
    Diaz-Gallo LM; Gourh P; Broen J; Simeon C; Fonollosa V; Ortego-Centeno N; Agarwal S; Vonk MC; Coenen M; Riemekasten G; Hunzelmann N; Hesselstrand R; Tan FK; Reveille JD; Assassi S; García-Hernandez FJ; Carreira P; Camps MT; Fernandez-Nebro A; de la Peña PG; Nearney T; Hilda D; González-Gay MA; Airo P; Beretta L; Scorza R; Herrick A; Worthington J; Pros A; Gómez-Gracia I; Trapiella L; Espinosa G; Castellvi I; Witte T; de Keyser F; Vanthuyne M; Mayes MD; Radstake TR; Arnett FC; Martin J; Rueda B
    Ann Rheum Dis; 2011 Mar; 70(3):454-62. PubMed ID: 21131644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
    Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.
    Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X
    Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
    Bossini-Castillo L; Simeon CP; Beretta L; Vonk MC; Callejas-Rubio JL; Espinosa G; Carreira P; Camps MT; Rodríguez-Rodríguez L; Rodríguez-Carballeira M; García-Hernández FJ; López-Longo FJ; Hernández-Hernández V; Sáez-Comet L; Egurbide MV; Hesselstrand R; Nordin A; Hoffmann-Vold AM; Vanthuyne M; Smith V; De Langhe E; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Voskuyl AE; Schuerwegh AJ; Lunardi C; Airó P; Scorza R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Koeleman BP; Rueda B; Radstake TR; Martin J;
    Rheumatology (Oxford); 2011 Nov; 50(11):1976-81. PubMed ID: 21875883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts.
    Coustet B; Agarwal SK; Gourh P; Guedj M; Mayes MD; Dieude P; Wipff J; Avouac J; Hachulla E; Diot E; Cracowski JL; Tiev K; Sibilia J; Mouthon L; Frances C; Amoura Z; Carpentier P; Meyer O; Kahan A; Boileau C; Arnett FC; Allanore Y
    J Rheumatol; 2011 Jun; 38(6):1033-8. PubMed ID: 21362770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the CTGF promoter region associated with systemic sclerosis.
    Fonseca C; Lindahl GE; Ponticos M; Sestini P; Renzoni EA; Holmes AM; Spagnolo P; Pantelidis P; Leoni P; McHugh N; Stock CJ; Shi-Wen X; Denton CP; Black CM; Welsh KI; du Bois RM; Abraham DJ
    N Engl J Med; 2007 Sep; 357(12):1210-20. PubMed ID: 17881752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.
    Coustet B; Bouaziz M; Dieudé P; Guedj M; Bossini-Castillo L; Agarwal S; Radstake T; Martin J; Gourh P; Elhai M; Koumakis E; Avouac J; Ruiz B; Mayes M; Arnett F; Hachulla E; Diot E; Cracowski JL; Tiev K; Sibilia J; Mouthon L; Frances C; Amoura Z; Carpentier P; Cosnes A; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    J Rheumatol; 2012 May; 39(5):997-1003. PubMed ID: 22422496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.
    Rueda B; Broen J; Simeon C; Hesselstrand R; Diaz B; Suárez H; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Coenen MJ; Airo P; Beretta L; Scorza R; van Laar J; Gonzalez-Escribano MF; Nelson JL; Radstake TR; Martin J
    Hum Mol Genet; 2009 Jun; 18(11):2071-7. PubMed ID: 19286670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.
    Chairta P; Psarelis S; Michailidou K; Demetriou C; Symeonidou S; Nicolaou P; Christodoulou K
    Genet Test Mol Biomarkers; 2020 May; 24(5):309-317. PubMed ID: 32315557
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis.
    Huang XL; Wu GC; Wang YJ; Yang XK; Yang GJ; Tao JH; Duan Y; Yan JW; Li XP; Ye DQ; Wang J
    Immunol Res; 2016 Aug; 64(4):1041-52. PubMed ID: 27098064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the CTGF -945C/G polymorphism and systemic sclerosis: a meta-analysis.
    Zhang X; Nie S; Si X; Luo Y; Tang W
    Gene; 2012 Nov; 509(1):1-6. PubMed ID: 22906474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
    Ochoa E; Martin JE; Assasi S; Beretta L; Carreira P; Guillén A; Simeón CP; Koumakis E; Dieude P; Allanore Y; García-Hernández FJ; Espinosa G; Castellví I; Trapiella JL; Rodriguez L; González-Gay MÁ; Egurbide MV; Sáez L; Callejas-Rubio JL; Vargas-Hitos JA; Hunzelmann N; Riemekasten G; Witte T; Distler JH; Kreuter A; Lunardi C; Santaniello A; Tan FK; Shiels PG; Herrick A; Worthington J; Vonk MC; Koeleman BP; Radstake TR; Mayes MD; Martin J;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S31-5. PubMed ID: 26314374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.